Key result
ADAMTS13 deficiency triggers preeclampsia-like disease via a ~6-fold increase in VWF adhesive activity.
Why the study?
Does hyperadhesive VWF contribute to the pathogenesis of preeclampsia?
Does hyperadhesive VWF contribute to the pathogenesis of preeclampsia?
Answers are grounded in this paper and cite their sources.
Hyperadhesive VWF plays a causal role in the pathogenesis of preeclampsia and represents a potential therapeutic target.
BACKGROUND: Preeclampsia is the most common complication of pregnancy, significantly affecting maternal and fetal health, and is characterized by placental and systemic endotheliopathy. Patients with preeclampsia have elevated levels of VWF (von Willebrand Factor), which is associated with poor clinical outcomes. However, whether VWF serves merely as a marker for endotheliopathy or contributes to the pathogenesis of preeclampsia remains poorly understood. METHODS: We investigated the role of hyperadhesive VWF in the development of preeclampsia by studying patients, evaluating the phenotype of mouse models, and performing in vitro experiments. RESULTS: We show that patients develop VWF- and fibrin-rich thrombosis in the placenta and have significantly elevated levels of VWF adhesive activity and placenta-derived extracellular vesicles. In mouse models, pregnant wild-type mice infused with hyperadhesive VWF alone, or in combination with placenta-derived extracellular vesicles, developed a preeclampsia-like condition, which was reduced by the VWF-cleaving metalloprotease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motif 13). Furthermore, ADAMTS13 -deficient mice with high baseline VWF (ADAMTS13 −/ −/casa ) developed a preeclampsia-like condition spontaneously, with VWF adhesive activity increasing 5.6-fold and placenta-derived extracellular vesicles increasing 2.9-fold during late pregnancy. VWF became hyperadhesive during pregnancy by undergoing conformational changes and promoted preeclampsia-associated endotheliopathy by enhancing the interaction of placenta-derived extracellular vesicles with endothelial cells. CONCLUSIONS: This study demonstrates that hyperadhesive VWF plays a causal role in preeclampsia and is a potential therapeutic target.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Preeclampsia. Hyperadhesive VWF was evaluated on Development of preeclampsia-like condition. Hyperadhesive VWF plays a causal role in preeclampsia, with ADAMTS13-deficient mice showing a 5.6-fold increase in VWF adhesive activity and spontaneously developing a preeclampsia-like condition.
Synapse has enriched 10 related papers. Consider them for comparative context: